Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplants can be used for rare types of scarring hair loss.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

People with Primary Cicatricial Alopecia have a higher risk of heart disease.

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

Low iron levels are linked to certain types of hair loss.

Hair transplantation is effective for treating cicatricial alopecia with fewer anesthesia risks, scars, and recovery time.

Combining FUE with rb-bFGF and minoxidil is more effective and has fewer side effects than FUE alone for treating hair loss.

Hair loss without scarring is more common than permanent hair loss with scarring, and is often due to genetic factors.

The document concludes that different patterns of hair thickness and scalp changes can help diagnose types of non-scarring hair loss.

Both follicular unit extraction and scalp expanders effectively treat secondary cicatricial alopecia, with scalp expanders leading to quicker and denser hair growth.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Early diagnosis and strong corticosteroids are crucial for managing lymphocytic cicatricial alopecia.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Certain inflammatory molecules and leptin may contribute to hair loss in cicatricial alopecia.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Hair loss in black women needs more research, early intervention, and community education.